Clinical Trials in San Francisco

Showing 1721-1740 of 11,161 trials

Prospective Registry of ADC as First- and Second-line Treatment for Breast Cancer

NCT06774027

Antibody-drug conjugates (ADCs) have demonstrated substantial improvement in progression free survival (PFS) and overall survival (OS) in phase III clinical trials in patients with metastatic triple negative breast cancer (mTNBC) and hormone receptor positive/HER2 negative (HR+/HER2-) metastatic breast cancer (MBC), offering an effective new treatment strategy. Several outstanding questions drive the decision to use ADC drugs clinically. This is a prospective, multi-site observational study of patients with metastatic breast cancer (mBC) who are being treated with FDA-approved antibody drug conjugates (ADCs) as part of routine care and aims to collect real-world data to evaluate the impact of ADC treatment as part of routine care.

HER2-negative Breast CancerHER2 Negative Breast CarcinomaMetastatic Breast Cancer+3 more

University of California, San Francisco100 participantsStarted Oct 2025

San Francisco, California, United States

RECRUITING< 1 mile

Blue Light Cystoscopy With Cysview® Registry

NCT02660645

Registry study to gather more information on the current use of Blue Light Cystoscopy with Cysview (BLCC) in urologists' practices.

Bladder Cancer

Photocure4,400 participantsStarted Apr 2014

Birmingham, Alabama, United States • Phoenix, Arizona, United States • Los Angeles, California, United States +20 more locations

Prospective Registry of ADC as First- and Second-line Treatment for Breast Cancer

Blue Light Cystoscopy With Cysview® Registry

Find Trials by Condition in San Francisco

Safety and Usability of the Cionic Neural Sleeve for Parkinson's Disease

Study of Nivolumab and Ipilimumab in Children and Young Adults With INI1-Negative Cancers

A Phase 1/2 Study of AURN001 in Subjects With Corneal Edema Secondary to Corneal Endothelial Dysfunction (ABA-1)

A Multicenter, Prospective Blood Collection Study in a Kidney Transplant Population

HAELO: A Phase 3 Study to Evaluate NTLA-2002 in Participants With Hereditary Angioedema (HAE)

Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products

Study of Cabozantinib in Combination With Atezolizumab Versus Second NHT in Subjects With mCRPC

A Study of GSK5764227 in Participants With. Advanced Solid Tumors (EMBOLD PanTumor-101)

Implementing Scalable, PAtient-centered, Team-based, Technology-enabled Care for Adults With Type 2 Diabetes (iPATH)

Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)

SyncAV Post-Market Trial

A Study to Evaluate the Efficacy and Safety of CIN-102 (Deudomperidone) in Adults With Diabetic Gastroparesis

An Extension Study for Treatment of Moderately to Severely Active Ulcerative Colitis

STEP TEENS Weight Maintenance: A Research Study on How Well Semaglutide Helps Teenagers With Excess Body Weight to Lose Weight and Maintain Weight Loss

A First-in-Human, Phase 1 Study of TST003 in Subjects With Solid Tumors

CBT-I vs. MBTI for Traumatic Brain Injury (TBI)-Related Insomnia and Post-Traumatic Stress Symptoms

A Study of JNJ-64619178, an Inhibitor of PRMT5 in Participants With Advanced Solid Tumors, NHL, and Lower Risk MDS

Study of BMS-986315 Alone and in Combination With Nivolumab or Cetuximab in Participants With Advanced Solid Tumors